BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/10/2022 1:14:37 PM | Browse: 306 | Download: 597
 |
Received |
|
2022-03-21 01:17 |
|
Peer-Review Started |
|
2022-03-21 01:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-04-25 20:37 |
|
Revised |
|
2022-05-07 17:40 |
|
Second Decision |
|
2022-07-04 03:03 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-07-06 04:21 |
|
Articles in Press |
|
2022-07-06 04:21 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-07-26 00:37 |
|
Publish the Manuscript Online |
|
2022-08-10 13:14 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Stereotactic radiotherapy for intrahepatic cholangiocarcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Aditya Borakati, Farid Froghi, Ricky H Bhogal and Vasileios K Mavroeidis |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Vasileios K Mavroeidis, FICS, FRCS, MD, MSc, Surgeon, Department of Academic Surgery, The Royal Marsden NHS Foundation Trust, Fulham Road, London SW3 6JJ, United Kingdom. vasileios.mavroeidis@nhs.net |
| Key Words |
Cholangiocarcinoma; Intrahepatic; Stereotactic ablative radiotherapy; Stereotactic body radiotherapy; Radiotherapy; Liver cancer; Hepatectomy |
| Core Tip |
Intrahepatic cholangiocarcinoma (iCCA) maintains a dismal prognosis despite best available therapy. Complete surgical resection offers a potentially curative option but is feasible in a limited number of cases. This review explores the evolving role of stereotactic ablative radiotherapy (SABR) in the management of iCCA either as an adjuvant to surgical resection, or in cases or recurrent or unresectable disease. Data on the use of SABR as a neoadjuvant/downstaging modality are scarce. Notably, published studies are limited to predominantly retrospective case series. High quality prospective trials evaluating SABR are urgently needed. |
| Publish Date |
2022-08-10 13:14 |
| Citation |
Borakati A, Froghi F, Bhogal RH, Mavroeidis VK. Stereotactic radiotherapy for intrahepatic cholangiocarcinoma. World J Gastrointest Oncol 2022; 14(8): 1478-1489 |
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i8/1478.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i8.1478 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
